Please wait while we open this resource.
K
Clinical reviews
ASSOCIATION OF BETA- BLOCKERS BEYOND 1 YEAR AFTER MYOCARDIAL INFARCTION AND CARDIOVASCULAR OUTCOMES
Uppsala University
PDF20237 pages1.4 MB
Beta-blockers are commonly prescribed after myocardial infarction (MI) for secondary prevention of cardiovascular events. However, there is uncertainty regarding their effectiveness beyond the first year post-MI, particularly in patients who do not have heart failure or left ventricular systolic dysfunction. This nationwide cohort study aims to clarify the association between prolonged beta-blocker therapy and cardiovascular outcomes in this specific patient population.
Sign in to open
Ask this resource
Answers use this document only.
Your first question is free.
More like this
Resources from the same specialty and type. Curated links will replace these when added.
Clinical Resources
Documents that extend or complement this resource.
SURVIVAL AFTER INITIAL STRESS TESTING VS ANATOMIC TESTING IN SUSPECTED CORONARY ARTERY DISEASE
Same clinical topic · Cardiology
PRACTICAL CARDIO-ONCOLOGY
Same clinical topic · Cardiology
OXFORD CARDIOLOGY LIBRARY: Hypertension
Same clinical topic · Cardiology
CARDIAC INVOLVEMENT IN PARASITIC INFECTIONS
Same clinical topic · Cardiology
The Athlete’s ECG
Same clinical topic · Cardiology
Antigen carbohydrate 125 as a biomarker in heart failure: a narrative review
Same clinical topic · Cardiology
Current ECG Aspects of Interatrial Block
Same clinical topic · Cardiology
Arrhythmic mitral valve prolapse in 2023: Evidence-based update
Same clinical topic · Cardiology
INTERPRETING THE NORMAL PACEMAKER
Same clinical topic · Cardiology